Cargando…
Metabolic Modifications, Inflammation, and Cancer Immunotherapy
Cancer immunotherapy has accomplished significant progresses on treatment of various cancers in the past decade; however, recent studies revealed more and more heterogeneity in tumor microenvironment which cause unneglectable therapy resistance. A central phenomenon in tumor malignancy is metabolic...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497755/ https://www.ncbi.nlm.nih.gov/pubmed/34631531 http://dx.doi.org/10.3389/fonc.2021.703681 |
_version_ | 1784580022352216064 |
---|---|
author | Zheng, Sihao Song, Qibin Zhang, Pingfeng |
author_facet | Zheng, Sihao Song, Qibin Zhang, Pingfeng |
author_sort | Zheng, Sihao |
collection | PubMed |
description | Cancer immunotherapy has accomplished significant progresses on treatment of various cancers in the past decade; however, recent studies revealed more and more heterogeneity in tumor microenvironment which cause unneglectable therapy resistance. A central phenomenon in tumor malignancy is metabolic dysfunctionality; it reprograms metabolic homeostasis in tumor and stromal cells thus affecting metabolic modifications on specific proteins. These posttranslational modifications include glycosylation and palmitoylation, which usually alter the protein localization, stability, and function. Many of these proteins participate in acute or chronic inflammation and play critical roles in tumorigenesis and progression. Therefore, targeting these metabolic modifications in immune checkpoints and inflammation provides an attractive therapeutic strategy for certain cancers. In this review, we summarize the recent progresses on metabolic modifications in this field, focus on the mechanisms on how glycosylation and palmitoylation regulate innate immune and inflammation, and we further discuss designing new immunotherapy targeting metabolic modifications. We aim to improve immunotherapy or targeted-therapy response and achieve more accurate individual therapy. |
format | Online Article Text |
id | pubmed-8497755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84977552021-10-09 Metabolic Modifications, Inflammation, and Cancer Immunotherapy Zheng, Sihao Song, Qibin Zhang, Pingfeng Front Oncol Oncology Cancer immunotherapy has accomplished significant progresses on treatment of various cancers in the past decade; however, recent studies revealed more and more heterogeneity in tumor microenvironment which cause unneglectable therapy resistance. A central phenomenon in tumor malignancy is metabolic dysfunctionality; it reprograms metabolic homeostasis in tumor and stromal cells thus affecting metabolic modifications on specific proteins. These posttranslational modifications include glycosylation and palmitoylation, which usually alter the protein localization, stability, and function. Many of these proteins participate in acute or chronic inflammation and play critical roles in tumorigenesis and progression. Therefore, targeting these metabolic modifications in immune checkpoints and inflammation provides an attractive therapeutic strategy for certain cancers. In this review, we summarize the recent progresses on metabolic modifications in this field, focus on the mechanisms on how glycosylation and palmitoylation regulate innate immune and inflammation, and we further discuss designing new immunotherapy targeting metabolic modifications. We aim to improve immunotherapy or targeted-therapy response and achieve more accurate individual therapy. Frontiers Media S.A. 2021-09-24 /pmc/articles/PMC8497755/ /pubmed/34631531 http://dx.doi.org/10.3389/fonc.2021.703681 Text en Copyright © 2021 Zheng, Song and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zheng, Sihao Song, Qibin Zhang, Pingfeng Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title | Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title_full | Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title_fullStr | Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title_full_unstemmed | Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title_short | Metabolic Modifications, Inflammation, and Cancer Immunotherapy |
title_sort | metabolic modifications, inflammation, and cancer immunotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497755/ https://www.ncbi.nlm.nih.gov/pubmed/34631531 http://dx.doi.org/10.3389/fonc.2021.703681 |
work_keys_str_mv | AT zhengsihao metabolicmodificationsinflammationandcancerimmunotherapy AT songqibin metabolicmodificationsinflammationandcancerimmunotherapy AT zhangpingfeng metabolicmodificationsinflammationandcancerimmunotherapy |